Systematic review: outcomes and adverse events from randomised trials in Crohn's disease
Author:
Affiliation:
1. Department of Biostatistics; University of Liverpool; Liverpool UK
2. Centre for Health Economics and Medicines Evaluation; Bangor University; Bangor UK
3. Digestive Diseases Centre; Aintree University Hospital NHS Trust; Liverpool UK
Funder
Medical Research Council
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15174/fullpdf
Reference209 articles.
1. Review article: Crohn's disease: monitoring disease activity;Sostegni;Aliment Pharmacol Ther,2003
2. Optimising monitoring in the management of Crohn's disease: a physician's perspective;Papay;J Crohn's Colitis,2013
3. Standardising outcomes for clinical trials and systematic reviews;Clarke;Trials,2007
4. Developing core outcome sets for clinical trials: issues to consider;Williamson;Trials,2012
5. Development of the first disability index for inflammatory bowel disease based on the international classification of functioning, disability and health;Peyrin-Biroulet;Gut,2012
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn’s Disease;Inflammatory Bowel Diseases;2024-09-04
2. Baseline Data and Measurement Instruments Reported in Observational Studies in Inflammatory Bowel Disease: Results from a Systematic Review;Journal of Crohn's and Colitis;2024-01-12
3. Comparison of treatment effect between phase 2 and phase 3 trials in patients with inflammatory bowel disease;United European Gastroenterology Journal;2023-09-05
4. Costs of Healthcare for Children with Inflammatory Bowel Diseases (IBD) in Poland;Children;2023-06-26
5. Impact of biologic therapies and small molecules on the risk of major adverse cardiovascular events in patients with inflammatory bowel diseases: systematic review and meta-analysis of randomized controlled trials;Expert Review of Gastroenterology & Hepatology;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3